Nasdaq
$16.49▼ 0.90%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $87.4MShares out 5.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
17- 4d agoAfter-hours26.10.21 06:324Ownership#●●●
Rallybio Corp
Rallybio Corp executive Paula Soteropoulos filed a Form 4 on October 20, 2026, reporting a change in beneficial ownership of securities as of October 16, 2026. This filing serves as a standard regulatory disclosure of insider stock holdings.…more
$16.49-0.90%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoAfter-hours26.10.21 06:294Ownership
Rallybio Corp
Rallybio Corp executive Helen M. Boudreau reported a change in beneficial ownership of securities as of October 16, 2026. This filing serves as a Form 4 statement regarding insider share activity.…more
$16.49-0.90%vs prev closeView filingShare - 10.16Pre-market26.10.16 13:15filedEFFECTOther
Rallybio Corp
The registration statement for Rallybio Corp (RLYB) was declared effective by the SEC on October 15, 2026. This filing confirms that the company's registration documents have been approved, completing the legal requirements for potential securities offerings or capital raising.…more
$16.49-0.90%vs prev closeView filingShare
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.9After-hours26.09.10 05:35#●●●#●●●
Rallybio CFO to Transition to Part-Time Role Amid Avenzo Therapeutics Merger…more
Rallybio CFO Jonathan Lieber will transition to a part-time role effective September 15 and will depart upon the closing of the Avenzo Therapeutics business combination. This leadership change is part of the ongoing merger process between the two companies.…more
$16.49-0.90%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga